Epsilon M&A Deal Report - Prodiag
Transaction Multiples for the Valuation of Private Companies
Biosynex / Prodiag
No EMAT :
78171
Announced Date :
23/04/2015
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Biosynex
Target :
Prodiag
Country :
France
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Diagnostic Medical Equipment
Business Description :
Founded in 2008, Prodiag develops and markets medical diagnostic products. > Operates the 3 following companies: All Diag Dectra Pharm Laboratoires Conforma > Main French player in the markets of...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Diagnostic Medical Equipment » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 14/09/2015 | Cantel Medical | Medical Innovations Group Holdings | United Kingdom | *** | 78155 |
| 17/12/2015 | CooperSurgical | Research Instruments | United Kingdom | ** | 78139 |
Source: Epsilon Research / EMAT
